Skip to Main Content

Paper Details

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.
J Natl Cancer Inst
20
2015
Cancer, blood specimens, cancer
Author NameAffiliation
Sheri D SchullyNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Leah E MechanicNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Leah E MechanicNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Sudhir SrivastavaNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Sudhir SrivastavaNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
John A BaronNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Christine D BergNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Eleftherios P DiamandisNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Katrina A B GoddardNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Susan E HankinsonNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Lawrence H KushiNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Eric B LarsonNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Steven J SkatesNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
Muin J KhouryNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
David F RansohoffNational Cancer Institute, Fred Hutchinson Cancer Research Center, University of North Carolina, Johns Hopkins Medicine, MD (CDB) Center for Prostate Disease Research, MD (JC) Mount Sinai Hospital, Canada (EPD) Center for Health Research, Kaiser Permanente, University of Massachusetts, CA (LHK) Group Health Research Institute, WA (EBL) American Society of Clinical Oncology, Inc., Massachusetts General Hospital, Centers for Disease Control and Prevention
  • 1 - 15

Datasets